Placebo-controlled Study of Single and Multiple Ascending Doses of UDP-003 in Healthy Human Participants and Followed by an Open-label Patient Cohort

Clinical trial NCT06813339 · RECRUITING

Trial details

NCT number: NCT06813339
Sponsor: Cyclarity Therapeutics, Inc.
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Atherosclerotic Cardiovascular Disease Acute Coronary Syndromes

Start date: 2025-02-25
Primary completion: 2026-12-30
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.